Market Access
Gain high value access and increase the profitability of your brands
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREBlog
Expanding Your Patient Support Program to Meet Individual Needs
Offering in-home healthcare for patients who need it the most
Jan 27, 2023
When innovative new therapies enter the market, they bring meaningful advances in treatment — but many newer specialty drugs are not as simple as taking a medication. Specialty therapies may have unique patient safety and appropriate use criteria that require lab tests, diagnostic tests and even monitoring prior to patients being cleared for therapy. Unfortunately, these complexities and requirements create barriers to patients starting and adhering to therapy.
Today, patients are more actively involved in their treatment decisions and expect a consumer-grade experience that includes meeting their needs where they are and when they need support. Most pharma manufacturers do not employ a nationwide network of clinicians who can go directly to patients in their homes to facilitate care. And without this capability, manufacturers miss an opportunity to positively impact patient satisfaction, in addition to delays in treatment onboarding. Even worse, patients who are candidates for the therapy may not start or stay on the prescribed treatment because they cannot (or choose not to) come to a clinical facility for a variety of reasons:
- Immunocompromised patients, due to a pre-existing condition or a therapy, for whom it is risky to leave home to get the required tests
- Patients with mobility challenges
- Medical centers that may have backlogs of several weeks for the testing needed to start therapy
IQVIA’s In-Home Clinical Solutions is a key element to tailored patient support programs (PSPs) across therapeutic categories, demonstrating how vital it is to meet the needs of patients prescribed complex therapies where they are and when they need support.
Here are a few examples:
- Multiple Sclerosis patients needing a drug in the S1P class and to be cleared for therapy must complete a basic blood test, ECG (Electrocardiogram), and/or ocular exam
- Rare disease patients needing a blood assay test to determine if they have a specific mutation to qualify as a candidate for gene therapy
- Breast cancer patients needing a baseline ECG to start therapy, and ongoing monthly ECG monitoring to stay on therapy
In the scenarios outlined above, pharma manufacturers implemented IQVIA’s In-Home Clinical Solutions and removed barriers to patient initiation of therapy and improved patient adherence to specialty therapies such as:
- Patients avoided waiting several weeks for a diagnostic test due to schedule back logs and in-home testing occurring on average <10 days
- Lab test results delivered to HCP within two days of in-home visit, allowing patients to start therapy earlier
- Adherence improved with patients needing ongoing monthly monitoring
- Patients with mobility challenges relieved burden from their caregiver to coordinate time and travel to the medical center
- Immunocompromised patients avoided the risk and expense of travel
IQVIA’s nationwide network of experienced clinicians possess the right knowledge, skills, mobile technology, and compassion for delivering clinical solutions to patients at home. Even in rural locations clinicians go to the patient directly, allowing the HCP to clear them for therapy faster, monitor patients receiving a first dose for potential side effects, and/or teach patients to self-inject in a one-on-one training session.
IQVIA’s clinical team are equipped with tablets that enable them to conduct patient surveys, education, and other services to assess patient satisfaction, capitalizing on over a decade of experience building trust and relationships throughout their patient interactions. And many patients, especially children, are more comfortable in the familiar environment of their own home rather than in a clinic. Patients also get privacy, convenience, and more control over their care with in-home clinical services. This results in a positive patient experience and a more satisfied customer, and for those requiring repeat visits, comfort knowing the clinician is one they have a personal connection with.
Improve Patient Satisfaction with In-Home Care
Today, patients are more actively involved in their treatment decisions and expect a consumer-grade experience that includes meeting their needs where they are and when they need support. Without a network of clinicians who can go directly to patients in their homes to facilitate care, access to critical therapies could be delayed and patient satisfaction can be negatively impacted. We share considerations for specialty therapy manufacturers on offering in-home healthcare to patients who need it the most.
Related solutions
Contract Sales and Medical Solutions
Deploy sales representatives, clinical nurse educators, field reimbursement specialists virtually or in the field to communicate the benefits of your therapy.